Scholarlink

Background <p>This study aimed to investigate the association between postoperative nadir serum potassium and 28-day mortality in patients undergoing surgical aortic valve replacement (SAVR) using the Medical Information Mart for Intensive Care (MIMIC-IV) database.</p> Methods <p>A retrospective cohort study included 2,877 patients undergoing SAVR from MIMIC-IV. The independent variable was postoperative nadir serum potassium, and the primary outcome was 28-day all-cause mortality. Logistic regression models adjusted for sex, age, BMI, use of beta-blockers, antidiabetic drugs, diuretics, comorbidities (COPD, heart failure, peripheral vascular disease), and indexes of kidney (BUN, Creatinine). Restricted cubic spline (RCS) regression assessed the potential nonlinear relationship, and Kaplan–Meier survival curves compared mortality risk across different serum potassium levels.</p> Results <p>A U-shaped relationship was observed between postoperative nadir potassium and 28-day all-cause mortality. Higher nadir potassium levels were significantly associated with reduced mortality (odds ratio [OR] = 0.40, 95% confidence interval [CI]: 0.24–0.69, <i>p</i> &lt; 0.001). The optimal threshold was 3.55 mmol/L; patients below this level had a markedly increased risk of death.</p> Conclusion <p>Lower postoperative nadir serum potassium is independently associated with increased 28-day mortality in SAVR patients. Maintaining postoperative nadir serum potassium no lower than 3.5 mmol/L may be associated with reduced short-term mortality, although this threshold should not be interpreted as a target level to be constantly maintained. The nadir value represents only the lowest single measurement during ICU stay and does not reflect overall potassium homeostasis.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

The association between postoperative nadir serum potassium and mortality within 28-day after aortic valve replacement

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月30日

查看全文
  • Haoran Zhang,
  • Shurui Zhang,
  • Shuyuxuan Song,
  • Xueying Li,
  • Xingchen Guo,
  • Meng Lv

摘要

Background

This study aimed to investigate the association between postoperative nadir serum potassium and 28-day mortality in patients undergoing surgical aortic valve replacement (SAVR) using the Medical Information Mart for Intensive Care (MIMIC-IV) database.

Methods

A retrospective cohort study included 2,877 patients undergoing SAVR from MIMIC-IV. The independent variable was postoperative nadir serum potassium, and the primary outcome was 28-day all-cause mortality. Logistic regression models adjusted for sex, age, BMI, use of beta-blockers, antidiabetic drugs, diuretics, comorbidities (COPD, heart failure, peripheral vascular disease), and indexes of kidney (BUN, Creatinine). Restricted cubic spline (RCS) regression assessed the potential nonlinear relationship, and Kaplan–Meier survival curves compared mortality risk across different serum potassium levels.

Results

A U-shaped relationship was observed between postoperative nadir potassium and 28-day all-cause mortality. Higher nadir potassium levels were significantly associated with reduced mortality (odds ratio [OR] = 0.40, 95% confidence interval [CI]: 0.24–0.69, p < 0.001). The optimal threshold was 3.55 mmol/L; patients below this level had a markedly increased risk of death.

Conclusion

Lower postoperative nadir serum potassium is independently associated with increased 28-day mortality in SAVR patients. Maintaining postoperative nadir serum potassium no lower than 3.5 mmol/L may be associated with reduced short-term mortality, although this threshold should not be interpreted as a target level to be constantly maintained. The nadir value represents only the lowest single measurement during ICU stay and does not reflect overall potassium homeostasis.